Development of Methods to Monitor Ionization Modification from Dosing Vehicles and Phospholipids in Study Samples

• Guidance for industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001.
   Google Scholar
• Committee for medicinal products for human use (CHMP): guideline on validation of bioanalytical methods (draft). London, UK 19 November 2009, Doc. Ref: EMEA/CHMP/EWP/192217/2009
   Google Scholar
• Guo XH , LankmayrE. Phospholipid- based matrix effects in LC–MS bioanalysis. Bioanalysis3, 349–352 (2011).
   PubMed Web of Science ®Google Scholar
• Bonfiglio R , KingR, OlahT, MerkleK. The effect of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 13, 1175–1185 (1999).
   PubMed Web of Science ®Google Scholar
• Shou W , WengND. Post-column infusion study of the ‘dosing vehicle effect’ in the liquid chromatography/tandem mass spectrometric analysis of discovery pharmacokinetic samples. Rapid Commun. Mass Spectrom. 17, 589–597 (2003).
   PubMed Web of Science ®Google Scholar
• Chang M , El-ShourbagyT. Throughput improvement of bioanalytical LC–MS/MS by sharing detector between HPLC systems. In:High-Throughput Analysis in the Pharmaceutical Industry. Wang PG (Ed.). CRC Oress, Boca Raton, FL, USA 119–140 (2009).
   Google Scholar
• Tong XS , WangJY, ZhengSet al. Effect of signal interference from dosing excipients on pharmacokinetic screen of drug candidates by liquid chromatography/mass spectrometry. Anal. Chem. 74, 6305–6313 (2000).
   Web of Science ®Google Scholar
• Ayorinde F , GelainS, JohnsonJ, WanJW. Analysis of some commercial polysorbate formulations using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 14, 2116–2126 (2000).
   PubMed Web of Science ®Google Scholar
• Little J , WempeM, BuchananC. Liquid chromatography-mass spectrometry method development for drug metabolism studies: examining lipid matrix ionization effects in plasma. J. Chromatography B. 822, 219–230 (2006).
   Web of Science ®Google Scholar
• Ismaiel O , HalquistM, ElmamlyM, ShalabyA, KarnesTK. Monitoring phospholipids for the assessment of ion enhancement and ion suppression in ESI and APCI LC–MS/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations. J. Chromatography B. 879, 333–343 (2008).
   Google Scholar
• Xia Y-Q , JemalM. Phospholipids in liquid chromatography/mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition of phospholipids elution and the association of phospholipids with matrix effects. Rapid Commun. Mass Spectrom. 23, 2125–2138 (2009).
   PubMed Web of Science ®Google Scholar
• Gosetti G , MuzzuccoE, Zampieri, Gennare M. Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry. J. Chrom. A1217, 3929–3937 (2010).
   PubMed Web of Science ®Google Scholar
• Mallet C , LuZL, MazzeoJ. A study of ion suppression effects in electrospray ionization from mobile phase additives and solid-phase extracts. Rapid Commun. Mass Spectrom. 18, 49–59 (2004).
   PubMed Web of Science ®Google Scholar
• Larger P , BredaM, FaierD, HughesH, JamesC. Ion-suppression effects in liquid chromatography–tandem mass spectrometry due to a formulation agent, a case study in drug discovery bioanalysis. J. Pharm. Biomed. Anal. 39, 206–216 (2008).
   Google Scholar
• Côté C , BergeronA, Mess J-N, Furtado M, Garofolo F. Matrix effect elimination during LC–MS/MS bioanalytical method development. Bioanalysis1, 1243–1257 (2009).
   PubMed Web of Science ®Google Scholar
• Mei H , HsiehYS, NardoCet al. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery. Rapid Commun. Mass Spectrom. 17, 97–103 (2003).
   PubMed Web of Science ®Google Scholar
• Schuhmacher J , ZimmerD, TescheF, PickardV. Matrix effects during analysis of plasma samples by electrospray and atmosphere pressure chemical ionization mass spectrometry: practical approaches to their elimination. Rapid Commun. Mass Spectrom. 17, 1959–1957 (2003).
   Google Scholar
• Eeckhaut A , LanckmanK, Sarre,S, SmoldersI, MichotteY. Validation of bioanalytical LC–MS/MS assays: evaluation of matrix effect. J. Chrom. B. 877, 2198–2207 (2009).
   PubMed Web of Science ®Google Scholar
• Hughes N , BajajN, FanJ, WongE. Assessing the matrix effects of hemolyzed samples in bioanalysis. Bioanalysis1, 1057–1066 (2009).
   PubMed Web of Science ®Google Scholar
• Liu GW , JiQ, ArnoldM. Identifying, evaluating and controlling bioanalytical risks results from non-uniform matrix ion suppression/enhancement and nonlinear liquid chromatography–mass spectrometry assay response. Anal. Chem. 82, 9671–9677 (2010).
   PubMed Web of Science ®Google Scholar
• Jian WY , EdomR, XuYD, GallagherJ, WengND. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC–MS/MS quantitation of the metabolites. J. Chrom. B. 878, 3267–3276 (2010).
   PubMed Web of Science ®Google Scholar
• Brockman A , HatsisP, PatonM, Wu J-T. Impact of differential recovery in bioanalysis: the example of bortezomib in whole blood. Anal. Chem. 79, 1599–1603 (2007).
   PubMed Web of Science ®Google Scholar

Website

• Gaussian smoothing. http://homepages.inf.ed.ac.uk/rbf/HIPR2/gsmooth.htm
   Google Scholar